Efficacy analysis of pectoralis major muscle flap transplantation for sternal infection after cardiac surgery
10.3760/cma.j.issn.1001-4497.2019.02.004
- VernacularTitle:胸大肌肌瓣移植治疗心脏术后胸骨感染疗效分析
- Author:
Xianjie LI
1
;
Runsheng ZHANG
;
Heng YANG
;
Wentong DONG
;
Pan JI
;
Xin CHANG
Author Information
1. 郑州心血管病医院郑州市第七人民医院心外科 450016
- Keywords:
Pectoralis major muscle flap;
Postcardiac surgery;
Sternal infection
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2019;35(2):76-79
- CountryChina
- Language:Chinese
-
Abstract:
To investigate the therapeutic effect of pectoralis major muscle flap transplantation in thoracotomy patients with sternal infection. Methods From January 2014 to December 2017, the treatment group of 39 patients with thoracic bone infection after cardiac surgery was used pectoralis major muscle flap to close the wound, while 26 patients were treated by debridement and vacuum sealing drainagea at the same time as the control group. The hospitalization time, hospital costs, number of operations, satisfaction survey, and relapse rate were compared between the those. Results Compared with the control group, the treatment group has the benefit of shorter hospitalization time [(18. 1 ± 3. 8)days vs. (36. 7 ± 11. 4) days], less hospital costs [(19429 ±4088)yuan vs. (33495 ±10712)yuan], less number of operations [(1. 1 ±0. 3)times vs. (2. 4 ±0. 8)times], higher level of satisfaction(56. 4％ vs. 30. 8％), lower relapse rate(5. 1％ vs. 26. 9％), the differences are statistically significant(all P <0. 05). Conclusion Thoracic reconstruction with pectoralis major muscle flap is an effective treatment for sternal infection in postcardiac surgery.
